Sartorius Aktiengesellschaft (ETR:SRT)
Market Cap | 15.02B |
Revenue (ttm) | 3.38B |
Net Income (ttm) | 84.00M |
Shares Out | n/a |
EPS (ttm) | 1.22 |
PE Ratio | 178.85 |
Forward PE | n/a |
Dividend | 0.73 (0.39%) |
Ex-Dividend Date | Mar 28, 2025 |
Volume | 599 |
Average Volume | 3,209 |
Open | 187.20 |
Previous Close | 196.00 |
Day's Range | 193.80 - 197.80 |
52-Week Range | 164.60 - 290.00 |
Beta | 1.04 |
RSI | 45.12 |
Earnings Date | Jan 28, 2025 |
About ETR:SRT
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quar... [Read more]
Financial Performance
In 2024, ETR:SRT's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.
Financial StatementsNews

EQS-News: Sartorius releases Annual Report for 2024
EQS-News: SARTORIUS AG / Key word(s): Annual Report Sartorius releases Annual Report for 2024 17.02.2025 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Götting...

EQS-News: The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share
EQS-News: SARTORIUS AG / Key word(s): Dividend The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share (news with additional features) 07.02.2025 / 15:48 CET/CEST ...
Sartorius Aktiengesellschaft (SARTF) Q4 2024 Earnings Call Transcript

Sartorius lifts U.S. peers after 2024 results
Sartorius (SARTF) jumps as the company projects a positive outlook with its 2024 results sending its U.S. peers, Repligen (RGEN) and Bio-Rad (BIO) higher. Read more here.
Sartorius Aktiengesellschaft Non-GAAP EPS of €4.05, revenue of €3.38B; initiates FY25 soft outlook
Sartorius Aktiengesellschaft press release (SARTF): FY Non-GAAP EPS of €4.05. Revenue of €3.38B (-0.3% Y/Y). Order intake + 10.8 percent, demand increasingly picking

Sartorius Vz. Surges in Q4, Hits 2024 Targets with Positive Momentum
Sartorius concluded 2024 triumphantly, exceeding expectations with a 10.8% order intake rise and a promising outlook for 2025 amidst industry challenges. Jetzt den vollständigen Artikel lesen

EQS-News: Sartorius closes fiscal 2024 with very good fourth quarter and positive trend; full-year guidance achieved
EQS-News: SARTORIUS AG / Key word(s): Annual Results/Quarter Results Sartorius closes fiscal 2024 with very good fourth quarter and positive trend; full-year guidance achieved (news with additional fe...
Danaher, Cryoport, Sartorius win Buy as Guggenheim expands bioprocessing coverage
ESG Roundup: Market Talk
Gain insight on Macy’s response to activist investors, Sartorius’s new CEO and more in the latest Market Talks covering ESG Impact Investing.

EQS-News: Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG
EQS-News: SARTORIUS AG / Key word(s): Personnel Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG (news with additional features) 06.12.2024 / 18:21 CET/CEST The i...

EQS-Adhoc: SARTORIUS AG: Michael Grosse to become Chief Executive Officer of Sartorius AG
EQS-Ad-hoc: SARTORIUS AG / Key word(s): Personnel SARTORIUS AG: Michael Grosse to become Chief Executive Officer of Sartorius AG 06-Dec-2024 / 18:17 CET/CEST Disclosure of an inside information acc. t...

Betting on Growth: 4 Favorite Stocks From T. Rowe Price's Peter Bates
The manager of the Global Select Equity Strategy looks for high margins, cash generation, competitive advantages, and a long runway of growth.
Sartorius Aktiengesellschaft (SARTF) Q3 2024 Earnings Call Transcript
Sartorius Aktiengesellschaft reports nine-month results

Strong Nine-Month Results: Sales Steady, Orders Up, Profit & Cash Flow Rise
Sartorius AG's latest financial results reveal a mixed performance, with a slight dip in sales but a boost in order intake. The company remains optimistic, confirming its outlook for 2024. Jetzt den v...

EQS-News: Nine-month results in line with expectations: sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash flow
EQS-News: SARTORIUS AG / Key word(s): 9 Month figures Nine-month results in line with expectations: sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash f...

'We are in a year of transition,' says Sartorius CEO
Sartorius CEO Joachim Kreuzburg discusses the pharmaceutical industry and his business outlook.

Sartorius Aktiengesellschaft (SARTF) Q1 2024 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q1 2024 Earnings Conference Call April 18, 2024 7:00 AM ET Corporate Participants Dr. Joachim Kreuzburg - Chairman René Fáber - Chief Executive Officer Flori...

Sartorius Aktiengesellschaft (SARTF) Q4 2023 Earnings Call Transcript
Sartorius Aktiengesellschaft (SARTF) Q4 2023 Earnings Call Transcript

10 stocks for investors looking for ‘wonderful companies at a fair price'
As money managers talk about various methods of selecting quality companies, investors might also think about diversification, which can lower risk and broaden opportunities.

These 5 DAX index companies are in trouble as their stocks plunge
German stocks are not doing well as the economy goes through substantial challenges. The most recent data showed that business confidence has tumbled while manufacturing and services PMIs have remaine...

Sartorius Aktiengesellschaft (SARTF) Q2 2023 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q2 2023 Earnings Conference Call July 21, 2023 9:30 AM ET Company Participants Joachim Kreuzburg - Chairman of the Executive Board and Chief Executive Office...

Sartorius: A German Champion With A Discounted Price
Sartorius has been experiencing a demand decline since 2022. Sartorius serves a niche market, which gives it a strong moat. Sartorius benefits from the long-term tailwinds of its sector.

Sartorius Aktiengesellschaft (SARTF) Q1 2023 Earnings Call Transcript
Sartorius Aktiengesellschaft (SARTF) Q1 2023 Earnings Call Transcript.

Sartorius, Sartorius Stedim shares fall after Polyplus acquisition
Shares in German pharmaceutical and laboratory equipment supplier Sartorius AG and its France-listed subsidiary Sartorius Stedim Biotech SA DIM, -6.51% fell in opening trade on Friday after the compan...